menu
    • menu
    [{"orgOrder":0,"company":"Chimagen Biosciences","sponsor":"GSK","pharmaFlowCategory":"D","therapeuticArea":"Immunology","country":"","productType":"Cell and Gene therapy","year":"2024","type":"Acquisition","leadProduct":"CMG1A46","moa":"","graph1":"Technology","graph2":"Phase I\/II","graph3":"Chimagen Biosciences","amount2":0.84999999999999998,"highestDevelopmentShortName":"","therapeuticAreaShortName":"Technology","amount2New":0.94999999999999996,"dosageForm":"","sponsorNew":"Chimagen Biosciences \/ GSK","highestDevelopmentStatusID":"14","companyTruncated":"Chimagen Biosciences \/ GSK"}]

    Find Clinical Drug Pipeline Developments & Deals by Chimagen Biosciences

    Menu

    Chimagen Biosciences

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Chimagen Biosciences

                            China arrow
                            Fi Europe 2024
                            Not Confirmed

                            Chimagen Biosciences

                            China arrow
                            Fi Europe 2024
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : CMG1A46

                            Therapeutic Area : Immunology

                            Study Phase : Preclinical

                            Sponsor : GSK

                            Deal Size : $850.0 million

                            Deal Type : Acquisition

                            DEALS_DEV arrow-down

                            GSK to Acquire Chimagen’s CMG1A46 for Autoimmune Disease

                            Details : Through the acquisition, GSK plans to develop and commercialize CMG1A46 with a focus on B cell-driven autoimmune diseases, such as systemic lupus erythematosus (SLE) and lupus nephritis.

                            Brand Name : CMG1A46

                            Molecule Type : Cell and Gene therapy

                            Upfront Cash : $300.0 million

                            October 29, 2024

                            Lead Product(s) : CMG1A46

                            Therapeutic Area : Immunology

                            Highest Development Status : Preclinical

                            Sponsor : GSK

                            Deal Size : $850.0 million

                            Deal Type : Acquisition

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth